The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study

Scritto il 10/12/2025
da Annunziata Raimondo

No abstract

J Am Acad Dermatol. 2025 Dec 9:S0190-9622(25)03250-5. doi: 10.1016/j.jaad.2025.11.047. Online ahead of print.

NO ABSTRACT

PMID:41369607 | DOI:10.1016/j.jaad.2025.11.047